Key result
Beta-blockers effectively prevent atrial fibrillation after cardiac surgery and should be part of routine medication, while amiodarone can be considered for high-risk patients.
Why the study?
Do beta-blockers prevent atrial fibrillation in patients undergoing cardiac surgery?
Do beta-blockers prevent atrial fibrillation in patients undergoing cardiac surgery?
Beta-blockers should be routinely used to prevent atrial fibrillation after cardiac surgery unless contraindicated.
Answers are grounded in this paper and cite their sources.
Supports beta-blocker prophylaxis after cardiac surgery; leaves open randomized confirmation for amiodarone in high-risk patients.
Atrial fibrillation is the most common arrhythmia occurring after heart surgery. Its prevalence after coronary artery bypass surgery is 17-33%. Atrial fibrillation requires additional treatment, lengthens hospitalization and increases the overall expenses of cardiac surgery. Atrial fibrillation can cause hemodynamic problems, predispose to congestive heart failure and increase the risk of stroke. Beta-blockers have been shown to effectively prevent atrial fibrillation, and beta-blockers should be a part of the medication of every patient undergoing cardiac surgery, if there are no contraindications. Amiodarone therapy can also be considered for especially high-risk patients.
No takes yet. Share an insight, caveat, or question.
Hakala et al. (2006) conducted a review in Atrial fibrillation after cardiac surgery. Beta-blockers was evaluated. Beta-blockers effectively prevent atrial fibrillation after cardiac surgery and should be part of routine medication, while amiodarone can be considered for high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: